Infanrix Polio

Diphtheria toxoid, tetanus toxoid, acellular pertussis, inactivated poliovirus vaccine, the active ingredient in Infanrix Polio, is a vaccine presented as an injectable solution for intramuscular use. It induces active immunity against diphtheria, tetanus, pertussis and poliomyelitis in infants and young children. It is routinely administered as part of national immunisation schedules to protect children from these serious bacterial and viral diseases.

GNH USA supplies Infanrix Polio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring quality‑controlled distribution and regulatory compliance across multiple markets.

Infanrix Polio is a combination vaccine that provides active immunisation against several bacterial and viral pathogens.

- Diphtheria: prevents diphtheria infection by stimulating protective antibodies. - Tetanus: prevents tetanus disease through antibody formation. - Pertussis: reduces risk of whooping cough by inducing immunity. - Poliomyelitis: protects against poliovirus‑induced paralysis by generating neutralising antibodies.

Infanrix Polio may be associated with local and systemic reactions following injection.

Common Side Effects: - Pain, redness or swelling at the injection site. - Low‑grade fever within 24‑48 hours. - Irritability or reduced appetite in infants.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) requiring immediate medical attention. - High fever or seizures occurring shortly after vaccination. - Persistent crying, hypotonic hyporesponsive episode, or encephalopathy, which are rare but warrant prompt evaluation.

Before administering Infanrix Polio, consider the following precautions.

- Assess prior allergic reactions: verify no severe hypersensitivity to any vaccine component. - Delay vaccination if moderate or severe acute illness is present. - Observe for 15 minutes post‑injection: monitor for immediate allergic reactions. - Avoid use in individuals with known immunodeficiency without specialist advice. - Do not co‑administer with live vaccines at the same site. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Infanrix Polio may interact with other medicines or vaccines.

Major Interactions (Avoid): - Live vaccines: concurrent administration may reduce immunogenicity of live vaccines. - Immunoglobulin therapy: may interfere with vaccine response if given within 2 weeks. - Blood products: may diminish antibody development if administered shortly after vaccination.

Moderate Interactions (Monitor Closely): - Antipyretics: may mask fever, but do not affect immune response. - Corticosteroids: high‑dose may blunt antibody production, monitor titres. - Concurrent administration with other injectable vaccines: follow recommended intervals to avoid local reactions.